Cargando…
Identification of LDH-A as a therapeutic target for cancer cell killing via (i) p53/NAD(H)-dependent and (ii) p53-independent pathways
Most cancer cells use aerobic glycolysis to fuel their growth. The enzyme lactate dehydrogenase-A (LDH-A) is key to cancer's glycolytic phenotype, catalysing the regeneration of nicotinamide adenine dinucleotide (NAD(+)) from reduced nicotinamide adenine dinucleotide (NADH) necessary to sustain...
Autores principales: | Allison, S J, Knight, J R P, Granchi, C, Rani, R, Minutolo, F, Milner, J, Phillips, R M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035693/ https://www.ncbi.nlm.nih.gov/pubmed/24819061 http://dx.doi.org/10.1038/oncsis.2014.16 |
Ejemplares similares
-
p53, DNA damage, and NAD+ homeostasis
por: Pfister, Neil T, et al.
Publicado: (2014) -
A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
por: Ladds, Marcus J. G. W., et al.
Publicado: (2018) -
Induction of p53-dependent and p53-independent cellular responses by topoisomerase 1 inhibitors.
por: McDonald, A. C., et al.
Publicado: (1998) -
𝒟(−)lentiginosine-induced apoptosis involves the intrinsic pathway and is p53-independent
por: Minutolo, A, et al.
Publicado: (2012) -
Three-Dimensional Analysis of the Interactions between hLDH5 and Its Inhibitors
por: Poli, Giulio, et al.
Publicado: (2017)